CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Icosavax, Inc. - ICVX CFD

    10.47
    3.87%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Icosavax Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 10.08
    Open* 9.93
    1-Year Change* 198.2%
    Day's Range* 9.62 - 10.63
    52 wk Range 2.63-16.45
    Average Volume (10 days) 361.53K
    Average Volume (3 months) 5.66M
    Market Cap 508.42M
    P/E Ratio -100.00K
    Shares Outstanding 50.09M
    Revenue N/A
    EPS -2.22
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 1, 2023 10.47 0.54 5.44% 9.93 10.63 9.50
    Nov 30, 2023 10.08 -0.01 -0.10% 10.09 10.69 9.73
    Nov 29, 2023 10.20 0.09 0.89% 10.11 10.76 9.92
    Nov 28, 2023 10.35 -0.21 -1.99% 10.56 10.73 9.87
    Nov 27, 2023 11.11 0.40 3.73% 10.71 11.66 10.58
    Nov 24, 2023 10.92 0.78 7.69% 10.14 11.16 10.14
    Nov 22, 2023 10.16 0.11 1.09% 10.05 10.73 9.75
    Nov 21, 2023 10.12 -0.36 -3.44% 10.48 10.59 9.65
    Nov 20, 2023 10.73 -0.45 -4.03% 11.18 11.38 10.57
    Nov 17, 2023 11.22 1.74 18.35% 9.48 11.23 9.48
    Nov 16, 2023 9.25 0.37 4.17% 8.88 9.83 8.49
    Nov 15, 2023 9.24 0.95 11.46% 8.29 9.90 8.29
    Nov 14, 2023 8.04 1.17 17.03% 6.87 8.09 6.86
    Nov 13, 2023 6.85 0.34 5.22% 6.51 6.87 6.38
    Nov 10, 2023 6.81 0.28 4.29% 6.53 6.83 6.37
    Nov 9, 2023 6.57 -0.54 -7.59% 7.11 7.45 6.57
    Nov 8, 2023 7.33 0.29 4.12% 7.04 7.38 7.00
    Nov 7, 2023 7.24 0.14 1.97% 7.10 7.26 6.92
    Nov 6, 2023 7.13 0.20 2.89% 6.93 7.28 6.93
    Nov 3, 2023 7.07 0.13 1.87% 6.94 7.37 6.76

    Icosavax, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total revenue 0.582 7.802 1.616 0
    Revenue 0.582 7.802 1.616 0
    Total Operating Expense 95.64 74.417 20.326 5.398
    Selling/General/Admin. Expenses, Total 30.23 34.887 2.659 1.241
    Research & Development 65.41 38.776 17.667 4.157
    Operating Income -95.058 -66.615 -18.71 -5.398
    Interest Income (Expense), Net Non-Operating 3.3 -0.356 -0.144 0.101
    Net Income Before Taxes -91.758 -66.971 -18.854 -5.297
    Net Income After Taxes -91.758 -66.971 -18.854 -5.297
    Net Income Before Extra. Items -91.758 -66.971 -18.854 -5.297
    Net Income -91.758 -66.971 -18.854 -5.297
    Total Adjustments to Net Income 0 -0.672
    Income Available to Common Excl. Extra. Items -91.758 -66.971 -18.854 -5.969
    Income Available to Common Incl. Extra. Items -91.758 -66.971 -18.854 -5.969
    Diluted Net Income -91.758 -66.971 -18.854 -5.969
    Diluted Weighted Average Shares 39.7251 17.9659 37.5099 37.5099
    Diluted EPS Excluding Extraordinary Items -2.30982 -3.72767 -0.50264 -0.15913
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -2.30982 -3.68571 -0.50264 -0.15913
    Unusual Expense (Income) 0 0.754
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0 0 0 0 0
    Revenue 0 0 0 0 0
    Total Operating Expense 28.955 26.522 25.131 23.143 23.131
    Selling/General/Admin. Expenses, Total 9.129 9.165 8.938 7.659 7.311
    Research & Development 19.826 17.357 16.193 15.484 15.82
    Unusual Expense (Income) 0 0 0
    Operating Income -28.955 -26.522 -25.131 -23.143 -23.131
    Interest Income (Expense), Net Non-Operating 2.458 1.961 1.518 1.167 0.495
    Net Income Before Taxes -26.497 -24.561 -23.613 -21.976 -22.636
    Net Income After Taxes -26.497 -24.561 -23.613 -21.976 -22.636
    Net Income Before Extra. Items -26.497 -24.561 -23.613 -21.976 -22.636
    Net Income -26.497 -24.561 -23.613 -21.976 -22.636
    Income Available to Common Excl. Extra. Items -26.497 -24.561 -23.613 -21.976 -22.636
    Income Available to Common Incl. Extra. Items -26.497 -24.561 -23.613 -21.976 -22.636
    Diluted Net Income -26.497 -24.561 -23.613 -21.976 -22.636
    Diluted Weighted Average Shares 44.7708 41.2645 40.0304 39.749 39.594
    Diluted EPS Excluding Extraordinary Items -0.59184 -0.59521 -0.58988 -0.55287 -0.5717
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.59184 -0.59521 -0.58988 -0.55287 -0.5717
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total Current Assets 223.913 286.553 16.16 23.288
    Cash and Short Term Investments 218.307 279.082 13.114 23.079
    Cash 58.846 279.082 13.114 23.079
    Prepaid Expenses 4.545 5.829 0.662 0.209
    Other Current Assets, Total 1.061 1.642 2.384 0
    Total Assets 238.677 287.629 16.17 23.288
    Property/Plant/Equipment, Total - Net 14.764 1.076 0.01 0
    Total Current Liabilities 13.788 9.238 5.834 1.223
    Accounts Payable 2.892 3.899 1.918 0.799
    Accrued Expenses 6.304 2.78 0.833 0.17
    Notes Payable/Short Term Debt 0 0 0 0
    Other Current Liabilities, Total 4.592 2.559 3.083 0.254
    Total Liabilities 20.515 9.409 12.811 1.469
    Total Long Term Debt 0 0 4.947 0
    Long Term Debt 0 4.947 0
    Other Liabilities, Total 6.727 0.171 2.03 0.246
    Total Equity 218.162 278.22 3.359 21.819
    Redeemable Preferred Stock 0 30.062 30.062
    Common Stock 0.006 0.005 0.002 0.001
    Additional Paid-In Capital 404.386 372.284 0.393 0
    Retained Earnings (Accumulated Deficit) -185.827 -94.069 -27.098 -8.244
    Total Liabilities & Shareholders’ Equity 238.677 287.629 16.17 23.288
    Total Common Shares Outstanding 41.0956 39.1753 37.5099 37.5099
    Property/Plant/Equipment, Total - Gross 15.707 1.159
    Accumulated Depreciation, Total -0.943 -0.083
    Short Term Investments 159.461
    Other Equity, Total -0.403
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 235.307 251.699 202.168 223.913 228.732
    Cash and Short Term Investments 229.206 246.933 196.59 218.307 221.399
    Cash 63.239 155.073 49.341 58.846 64.505
    Prepaid Expenses 6.101 4.766 4.517 4.545 6.272
    Other Current Assets, Total 0 0 1.061 1.061 1.061
    Total Assets 251.296 269.026 219.673 238.677 243.877
    Property/Plant/Equipment, Total - Net 14.375 15.203 15.388 14.764 15.145
    Other Long Term Assets, Total 1.614 2.124 2.117
    Total Current Liabilities 13.03 15.014 12.901 13.788 13.033
    Accounts Payable 1.239 1.547 1.611 2.892 4.722
    Accrued Expenses 10.262 11.253 4.477 6.304 4.752
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 1.529 2.214 6.813 4.592 3.559
    Total Liabilities 18.916 21.304 19.59 20.515 18.215
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Other Liabilities, Total 5.886 6.29 6.689 6.727 5.182
    Total Equity 232.38 247.722 200.083 218.162 225.662
    Redeemable Preferred Stock
    Common Stock 0.007 0.007 0.006 0.006 0.005
    Additional Paid-In Capital 491.347 484.666 410.528 404.386 388.48
    Retained Earnings (Accumulated Deficit) -258.926 -236.885 -210.388 -185.827 -162.214
    Total Liabilities & Shareholders’ Equity 251.296 269.026 219.673 238.677 243.877
    Total Common Shares Outstanding 50.0886 49.9162 41.3459 41.0956 39.7874
    Short Term Investments 165.967 91.86 147.249 159.461 156.894
    Other Equity, Total -0.048 -0.066 -0.063 -0.403 -0.609
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Net income/Starting Line -91.758 -66.971 -18.854 -5.297
    Cash From Operating Activities -61.675 -38.54 -14.208 -4.569
    Cash From Operating Activities 0.86 0.082 0.001 0
    Non-Cash Items 24.731 30.254 0.487 0.072
    Changes in Working Capital 4.492 -1.905 4.158 0.656
    Cash From Investing Activities -169.449 -1.006 -0.011 0
    Capital Expenditures -11.113 -1.006 -0.011 0
    Cash From Financing Activities 10.307 304.772 6.638 26.742
    Issuance (Retirement) of Stock, Net 10.307 114.034 6.638 26.742
    Net Change in Cash -220.817 265.226 -7.581 22.173
    Financing Cash Flow Items 0 190.738
    Other Investing Cash Flow Items, Total -158.336
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -24.561 -91.758 -68.145 -46.169 -23.533
    Cash From Operating Activities -21.649 -61.675 -52.671 -35.293 -17.46
    Cash From Operating Activities 0.643 0.86 0.241 0.098 0.043
    Non-Cash Items 5.482 24.731 14.806 9.913 4.55
    Changes in Working Capital -3.213 4.492 0.427 0.865 1.48
    Cash From Investing Activities 12.027 -169.449 -162.707 -136.524 -1.122
    Capital Expenditures -1.573 -11.113 -8.563 -4.608 -1.122
    Cash From Financing Activities 0.117 10.307 0.22 0.499 0.276
    Issuance (Retirement) of Stock, Net 0.117 10.307 0.582 0.499 0.276
    Net Change in Cash -9.505 -220.817 -215.158 -171.318 -18.306
    Financing Cash Flow Items 0 -0.362 0
    Other Investing Cash Flow Items, Total 13.6 -158.336 -154.144 -131.916
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fidelity Management & Research Company LLC Investment Advisor 13.3732 6692846 690953 2023-06-30 LOW
    RA Capital Management, LP Hedge Fund 11.916 5963565 0 2023-06-30 LOW
    T. Rowe Price Investment Management, Inc. Investment Advisor 9.8611 4935120 267735 2023-06-30 LOW
    TCG Crossover Management, LLC Investment Advisor 7.4005 3703704 0 2023-06-30 MED
    Qiming U.S. Ventures Management, LLC Investment Advisor 7.0139 3510228 0 2023-06-30 LOW
    Platinum Asset Management Investment Advisor/Hedge Fund 4.6664 2335350 -114552 2023-06-30 LOW
    Citadel Advisors LLC Hedge Fund 4.366 2185010 -4459 2023-06-30 LOW
    Adams Street Partners, LLC Private Equity 4.3577 2180864 -36754 2023-06-30 LOW
    Logos Global Management LLC Investment Advisor 4.3275 2165741 2165741 2023-06-30 HIGH
    Vivo Capital, LLC Venture Capital 3.406 1704568 1704568 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 3.2584 1630704 457815 2023-06-30 LOW
    NanoDimension, Inc. Venture Capital 2.521 1261658 -100000 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.9311 966428 37944 2023-06-30 LOW
    Simpson (Adam K) Individual Investor 1.7706 886136 3000 2023-08-01 LOW
    Rock Springs Capital Management LP Hedge Fund 1.7352 868409 3899 2023-06-30 LOW
    Laurion Capital Management LP Hedge Fund 1.4833 742354 0 2023-06-30 HIGH
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.0055 503197 42194 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9907 495831 76542 2023-06-30 LOW
    Holtzman (Douglas Andrew) Individual Investor 0.6777 339161 0 2023-07-03 LOW
    Citi Investment Research (US) Research Firm 0.6443 322440 8201 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Icosavax, Inc. Company profile

    About Icosavax Inc

    Icosavax Inc. is a biopharmaceutical company. The Company uses its virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with a focus on respiratory diseases. Its VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens. The Company's pipeline includes vaccine candidates targeting viral causes of pneumonia. Its vaccine candidate IVX-A12 is a bivalent candidate, or a mixture of two different VLP candidates. IVX-A12 combines IVX-121, a vaccine candidate designed to target respiratory syncytial virus (RSV), and IVX-241, a vaccine candidate designed to target human metapneumovirus (hMPV). The Company is also developing two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates, IVX-411 and IVX-421, with a Phase I/II clinical trial of IVX-411.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Icosavax Inc revenues totaled $5.7M. Net loss totaled to $48.8M.

    Industry: Biotechnology & Medical Research (NEC)

    1930 Boren Ave., Suite 1000
    SEATTLE
    WASHINGTON 98101
    US

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    Oil - Crude

    74.50 Price
    -1.560% 1D Chg, %
    Long position overnight fee -0.0136%
    Short position overnight fee -0.0083%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    XRP/USD

    0.62 Price
    +0.160% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    16,001.20 Price
    +0.470% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    BTC/USD

    38,793.20 Price
    -0.170% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading